A review of clinical trials concluded that oral arginine increases growth hormone.<ref>{{cite journal |vauthors=Kanaley JA |title=Growth hormone, arginine and exercise |journal=Curr Opin Clin Nutr Metab Care |volume=11 |issue=1 |pages=50–4 |year=2008 |pmid=18090659 |doi=10.1097/MCO.0b013e3282f2b0ad |url=}}</ref> However, a more recent trial did not report an increase in growth hormone despite being effective at increasing plasma levels of <small>L</small>-arginine.<ref>{{cite journal |vauthors=Forbes SC, Bell GJ |title=The acute effects of a low and high dose of oral L-arginine supplementation in young active males at rest |journal=Appl Physiol Nutr Metab |volume=36 |issue=3 |pages=405–11 |year=2011 |pmid=21574873 |doi=10.1139/h11-035 |url=}}</ref>

 
Several trials delved into effects of <small>L</small>-arginine in [[Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes|Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS syndrome)]], an inherited [[mitochondrial disease]].<ref>{{cite journal |vauthors=El-Hattab AW, Almannai M, Scaglia F |title=Arginine and citrulline for the treatment of MELAS syndrome |journal=J Inborn Errors Metab Screen |volume=5 |issue= |pages= |year=2017 |pmid=28736735 |pmc=5519148 |doi= |url=}}</ref>
